These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9790103)

  • 21. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation].
    González-Guerra E; Requena L; Kutzner H
    Actas Dermosifiliogr; 2008; 99(6):456-63. PubMed ID: 18558053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
    East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
    Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression patterns of epithelial differentiation antigens and lectin-binding sites in ameloblastomas: a comparison with basal cell carcinomas.
    Vigneswaran N; Whitaker SB; Budnick SD; Waldron CA
    Hum Pathol; 1993 Jan; 24(1):49-57. PubMed ID: 7678093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Cribier B
    Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS3-VS11. PubMed ID: 30477681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME; Smith K; Corbett D; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
    Kazantseva IA; Khlebnikova AN; Babaev VR
    Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Profile of CD10, BCL-2, p63, and EMA in the Normal Skin and Basal Cell Carcinomas: An Immunohistochemical Reappraisal.
    Hussein MR; Ahmed AM
    Actas Dermosifiliogr; 2022 Oct; 113(9):848-855. PubMed ID: 35636508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas. An immunohistochemical study.
    Schulz T; Hartschuh W
    J Cutan Pathol; 1997 Jan; 24(1):14-24. PubMed ID: 9027628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
    Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary mesenchymal bodies: a histologic finding useful in differentiating trichoepitheliomas from basal cell carcinomas.
    Brooke JD; Fitzpatrick JE; Golitz LE
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):523-8. PubMed ID: 2778115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.
    Verhaegh ME; Sanders CJ; Arends JW; Neumann HA
    Br J Dermatol; 1995 May; 132(5):740-4. PubMed ID: 7772478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
    Kanoh M; Amoh Y; Sato Y; Katsuoka K
    Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of Basal Cell Carcinoma and Trichoepithelioma: An Immunohistochemical Study.
    Carrasquillo OY; Cruzval-O'Reilly E; Sánchez JE; Valentín-Nogueras SM
    Am J Dermatopathol; 2021 Mar; 43(3):191-197. PubMed ID: 32809979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.
    Ionescu DN; Arida M; Jukic DM
    Arch Pathol Lab Med; 2006 Jan; 130(1):45-51. PubMed ID: 16390237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma.
    Kannon G; Park HK
    Am J Dermatopathol; 1990 Feb; 12(1):31-6. PubMed ID: 2180338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas.
    Bozdogan O; Erkek E; Atasoy P; Koçak M; Birol A; Caydere M
    Acta Derm Venereol; 2002; 82(6):423-7. PubMed ID: 12575847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
    Thewes M; Worret WI; Engst R; Ring J
    Am J Dermatopathol; 1998 Apr; 20(2):140-2. PubMed ID: 9557781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunohistochemical characteristics of the basosquamous cell carcinoma.
    Jones MS; Helm KF; Maloney ME
    Dermatol Surg; 1997 Mar; 23(3):181-4. PubMed ID: 9145960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.